Thursday 23rd March 2023Companion diagnostics for precision medicineRoyal Society of Chemistry, London
This one-day symposium will address the development and need for companion diagnostics (CDx) for precision medicine applications. Companion diagnostics are becoming more and more important with time together with the growth of targeted therapies. Precision medicine approach aims to stratify patients with the ultimate aim of targeting patients who are most likely to respond to a specific treatment. Currently, CDx are used for many diseases lung cancer, colorectal cancer, breast cancer and melanoma.
At this symposium, delegates will be able to explore the current state of the art in vitro diagnostic tests used by the industry and explore the different scientific measurements that are needed to develop and deliver a CDx into the market.
CDx is a platform technology and can be used for many other diseases, join us and lets discuss the future of healthcare and personalised treatment.
Speakers:
Prof Felicity Boardman - University of Warwick
Dr Graham Fews - West Midlands Regional Genetics Lab / NHS
Prof George Hanna - Imperial College London
Prof Lorna Harries - University of Exeter / SENISCA
Dr Dahlia Salman - Bioxhale ltd
Dr Elizabeth Young - NHS
Prof Philip Young - University of Warwick
DETAILS AND REGISTRATION